AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cutaneous Metastasis

Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity NCT06945081NA2 sites๐Ÿ“ Bron๐Ÿ“ Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne ยท Tests: Preparation of forearm molds with SILFLOยฎ silicone TIL Therapy in cSCC and MCC NCT07288073Phase 21 site๐Ÿ“ Boston Karam Khaddour, MD, MS ยท Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma NCT07337161NA1 site๐Ÿ“ London David Palma ยท Tests: SBRT, Standard Radiation Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naรฏve, Cutaneous Melanoma Study NCT07050940NA5 sites๐Ÿ“ Bari๐Ÿ“ Torino๐Ÿ“ Bari Azienda Ospedaliera di Perugia ยท Tests: Postbiotic, AntiPD1 TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Resโ€ฆ A Study of IDP-001 in Advanced or Metastatic Solid Tumors NCT07602842Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ Indianapolis InduPro, Inc. ยท Tests: IDP-001 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors NCT06305962EARLY Phase 15 sites๐Ÿ“ Kingswood๐Ÿ“ Wollongong๐Ÿ“ Southport Radiopharm Theranostics, Ltd ยท Tests: 177Lu-RAD204 Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors NCT06171750Phase 15 sites๐Ÿ“ Bethesda๐Ÿ“ Boston๐Ÿ“ Portland Ankyra Therapeutics, Inc ยท Tests: tolododekin alfa, Cemiplimab (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma NCT05747625Phase 11 site๐Ÿ“ Nashville Eben Rosenthal ยท Tests: Panitumumab, Zirconium Zr 89 Panitumumab, Positron Emission Tomography, Computed Tomography, Electronic Health Record Rโ€ฆ Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma NCT07655570Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ivonescimab The Effect of Reduced Bleomycin in Electrochemotherapy Treatment NCT06647342Phase 42 sites๐Ÿ“ Herlev๐Ÿ“ Roskilde Julie Gehl ยท Tests: Bleomycin Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site๐Ÿ“ Columbus Carlo Contreras ยท Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases NCT04511013Phase 2331 sites๐Ÿ“ Birmingham๐Ÿ“ Fairhope๐Ÿ“ Mobile SWOG Cancer Research Network ยท Tests: Binimetinib, Encorafenib, Ipilimumab, Nivolumab Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors NCT04068155NA2 sites๐Ÿ“ Grenoble๐Ÿ“ Lyon Alpha Tau Medical LTD. ยท Tests: DaRT- Diffusing Alpha-emitters Radiation Therapy A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 NCT06887348n/a2 sites๐Ÿ“ La Jolla๐Ÿ“ Southport Replimune, Inc. ยท Tests: Observational study with no interventions Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma NCT06194929Phase 1, Phase 22 sites๐Ÿ“ Iowa City๐Ÿ“ Salt Lake City University of Utah ยท Tests: Defactinib, Avutometinib, Encorafenib Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients NCT06673628Phase 26 sites๐Ÿ“ Kashiwa๐Ÿ“ Kyoto๐Ÿ“ Miyazaki National Cancer Center, Japan ยท Tests: Pembrolizumab plus Lenvatinib Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC NCT05047094NA3 sites๐Ÿ“ Jerusalem๐Ÿ“ Ramat Gan๐Ÿ“ Tel Aviv Alpha Tau Medical LTD. ยท Tests: Diffusing Alpha Radiation Emitters Therapy (DaRT), Pembrolizumab Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade NCT07130032Phase 21 site๐Ÿ“ Saint Petersburg EuroCityClinic LLC ยท Tests: reICB regimen (NSCLC), reICB regimen (melanoma) Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961NA1 site๐Ÿ“ Toulouse Institut Claudius Regaud ยท Tests: For each enrolled patient, the sample described below will be collected as specific intervention intended for research โ€ฆ A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Rancho Santa Margarita๐Ÿ“ Weston Krystal Biotech, Inc. ยท Tests: KB707, Opdualag, KEYTRUDA ยฎ( Pembrolizumab) Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis NCT02422641Phase 23 sites๐Ÿ“ Baltimore๐Ÿ“ St Louis๐Ÿ“ Winston-Salem Wake Forest University Health Sciences ยท Tests: High-dose Methotrexate (8 gm/m2; HD-MTX) SUPRAME-ACTengineยฎ IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma NCT06743126Phase 371 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Immatics US, Inc. ยท Tests: IMA203, nivolumab plus relatlimab, lifileucel, nivolumab, pembrolizumab Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma NCT07404605NA1 site๐Ÿ“ Ljubljana Institute of Oncology Ljubljana ยท Tests: Electrochemotherapy ACTengineยฎ IMA203 Combined With mRNA-4203 NCT06946225Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ New York Immatics US, Inc. ยท Tests: IMA203, mRNA-4203 Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer NCT05098210Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC, Echocardiography Test, Multigated Acquisition Scan French National Database of Rare Dermatological Cancers NCT03210935n/a34 sites๐Ÿ“ Dijon๐Ÿ“ Le Mans๐Ÿ“ Pierre-Bรฉnite University Hospital, Lille Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases NCT05026983Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Binimetinib, Encorafenib, Questionnaire Administration Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy